The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to [...] READ MORE ...

Two PanCAN Patient Services Senior Case Managers share their thoughts on the importance of caregiving—and how we can all support the selfless, special caregivers in our lives.

We're the national organization providing support, resources, volunteer opportunities and hope for people fighting pancreatic cancer.

Editor’s Note: PanCAN volunteers devote their time, energy and passion year-round to improving the lives of everyone impacted by pancreatic cancer. To celebrate Volunteer Appreciation Week 2025 (April ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit outlines the latest advances in pancreatic cancer and offers key insights from ASCO GI 2025.

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...

The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called NRG1 gene fusion found in roughly 3% of patients with pancreatic ...

In a Phase III clinical trial, a therapy known as Tumor Treating Fields (TTFields) increased survival for patients whose pancreatic cancer had not spread to other organs but cannot be removed by ...

Anna Berkenblit, MD, MMSc, is looking forward to bringing her dual experience as a clinician and biotech executive to her new role as PanCAN’s Chief Scientific and Medical Officer.

For the first time in more than 10 years, the FDA has approved a new first-line treatment, called NALIRIFOX, for patients with metastatic pancreatic cancer.

For the third year in the row, the pancreatic cancer five-year survival rate has increased one percentage point, to 13%, according to the American Cancer Society’s Cancer Facts & Figures 2024 Report.

Despite advances in pancreatic cancer the disease is on track to become the second-leading cause of cancer-related deaths before 2030 LOS ANGELES, Calif. – (January 17, 2024) – The five-year survival ...